NIH begins trial of COVID boosters to fight future variants
Enlarge / A vial of the current Moderna COVID-19 vaccine. (credit: Getty | Ivan Romano) Mild or not, more SARS-CoV-2 variants are inevitable. To avoid any blips in our pandemic endgame, researchers at the National Institutes of Health on Thursday announced the start of a complex Phase II clinical trial to find the best COVID-19…












